JNK vs XLV
SPDR Bloomberg High Yield Bond ETF vs Health Care Select Sector SPDR Fund
JNK$96.20
SPDR Bloomberg High Yield Bond ETF
High-yield junk bonds.
Expense: 0.40%Yield: 6.59%
XLV$144.72
Health Care Select Sector SPDR Fund
S&P 500 health care sector.
Expense: 0.08%Yield: 1.72%
Quick take
- • XLV has the lower expense ratio at 0.08% vs 0.40% for JNK.
- • JNK pays a higher dividend yield (6.59%).
Side-by-side metrics
| Metric | JNK | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.40% | 0.08% |
Dividend yield Trailing 12-month yield. | 6.59% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $7.27B | $37.88B |
YTD return | 1.53% | -5.69% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.67 | 0.58 |
P/E ratio | 20.16 | 26.68 |
Last price | $96.20 | $144.72 |
Inception | — | — |
Issuer | State Street | State Street |
JNK top holdings
Holdings data unavailable for JNK.
Sector breakdown · JNK
Energy100.0%
XLV top holdings
Top holdings · XLV
| LLY | Eli Lilly and Co | 14.07% |
| JNJ | Johnson & Johnson | 10.52% |
| ABBV | AbbVie Inc | 7.10% |
| UNH | UnitedHealth Group Inc | 6.38% |
| MRK | Merck & Co Inc | 5.15% |
| AMGN | Amgen Inc | 3.54% |
| TMO | Thermo Fisher Scientific Inc | 3.42% |
| ISRG | Intuitive Surgical Inc | 3.09% |
| GILD | Gilead Sciences Inc | 3.08% |
| ABT | Abbott Laboratories | 3.00% |
Sector breakdown · XLV
Healthcare100.0%
About JNK
JNK (SPDR Bloomberg High Yield Bond ETF) is High-yield junk bonds. Managed by State Street, the fund carries $7.3B in assets under management, an expense ratio of 0.40%, a dividend yield of 6.59%. Energy is the fund's largest sector exposure at 100.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $37.9B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.